The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
2025 Nobel Prize in Medicine Spotlights the Mechanism of Cancer Immune Evasion
By The Cancer News Team
The 2025 Nobel Prize in Medicine honors the discovery of FOXP3 and regulatory T cells, revealing how immune tolerance prevents autoimmunity and shapes cancer immune evasion.
2025 Nobel Prize in Medicine Spotlights the Mechanism of Cancer Immune Evasion
By The Cancer News Team
The 2025 Nobel Prize in Medicine honors the discovery of FOXP3 and regulatory T cells, revealing how immune tolerance prevents autoimmunity and shapes cancer immune evasion.
2025 Nobel Prize in Medicine Spotlights the Mechanism of Cancer Immune Evasion
By The Cancer News Team
The 2025 Nobel Prize in Medicine honors the discovery of FOXP3 and regulatory T cells, revealing how immune tolerance prevents autoimmunity and shapes cancer immune evasion.
FDA approves Inluriyo (imlunestrant) for ER+, HER2-, ESR1-mutated metastatic breast cancer
By Shipra Gandhi, MD, MS
The FDA has approved imlunestrant (Inluriyo), a new oral SERD, for treating ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer, expanding targeted therapy options for patients with endocrine-resistant disease.
FDA approves Inluriyo (imlunestrant) for ER+, HER2-, ESR1-mutated metastatic breast cancer
By Shipra Gandhi, MD, MS
The FDA has approved imlunestrant (Inluriyo), a new oral SERD, for treating ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer, expanding targeted therapy options for patients with endocrine-resistant disease.
FDA approves Inluriyo (imlunestrant) for ER+, HER2-, ESR1-mutated metastatic breast cancer
By Shipra Gandhi, MD, MS
The FDA has approved imlunestrant (Inluriyo), a new oral SERD, for treating ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer, expanding targeted therapy options for patients with endocrine-resistant disease.
Breast Cancer 101
By Dr. Fengting Yan
Learn about breast cancer symptoms, prevention, treatment options, and disparities worldwide in this expert-reviewed overview by Dr. Fengting Yan of the Swedish Cancer Institute.
Breast Cancer 101
By Dr. Fengting Yan
Learn about breast cancer symptoms, prevention, treatment options, and disparities worldwide in this expert-reviewed overview by Dr. Fengting Yan of the Swedish Cancer Institute.
Breast Cancer 101
By Dr. Fengting Yan
Learn about breast cancer symptoms, prevention, treatment options, and disparities worldwide in this expert-reviewed overview by Dr. Fengting Yan of the Swedish Cancer Institute.
How One PhD Student Is Bridging Cervical Cancer Research and Community Impact
By The Cancer News Team
How one PhD student is bridging cervical cancer research and community outreach to improve prevention and treatment access in underserved regions of Nepal.
How One PhD Student Is Bridging Cervical Cancer Research and Community Impact
By The Cancer News Team
How one PhD student is bridging cervical cancer research and community outreach to improve prevention and treatment access in underserved regions of Nepal.
How One PhD Student Is Bridging Cervical Cancer Research and Community Impact
By The Cancer News Team
How one PhD student is bridging cervical cancer research and community outreach to improve prevention and treatment access in underserved regions of Nepal.
Meredith Pelster, MD, MSCI, on GI Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Meredith Pelster, MD, MSCI, discusses the challenges and emerging opportunities of cellular therapy in GI malignancies, highlighting insights from the 2025 Seattle Cellular Therapy Summit.
Meredith Pelster, MD, MSCI, on GI Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Meredith Pelster, MD, MSCI, discusses the challenges and emerging opportunities of cellular therapy in GI malignancies, highlighting insights from the 2025 Seattle Cellular Therapy Summit.
Meredith Pelster, MD, MSCI, on GI Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Meredith Pelster, MD, MSCI, discusses the challenges and emerging opportunities of cellular therapy in GI malignancies, highlighting insights from the 2025 Seattle Cellular Therapy Summit.
10 Prostate Cancer Myths vs. Facts: What Men Need to Know This Awareness Month
By Dr. Jordan Ciuro
Debunk the most common prostate cancer myths with evidence-based facts this Awareness Month and learn what men really need to know about prevention, screening, and treatment.
10 Prostate Cancer Myths vs. Facts: What Men Need to Know This Awareness Month
By Dr. Jordan Ciuro
Debunk the most common prostate cancer myths with evidence-based facts this Awareness Month and learn what men really need to know about prevention, screening, and treatment.
10 Prostate Cancer Myths vs. Facts: What Men Need to Know This Awareness Month
By Dr. Jordan Ciuro
Debunk the most common prostate cancer myths with evidence-based facts this Awareness Month and learn what men really need to know about prevention, screening, and treatment.
Rosa Nadal Rios, MD, PhD, on GU Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Rosa Nadal Rios, MD, PhD, shares insights on the future of cellular therapy in GU malignancies, highlighting advances in prostate, kidney, and testicular cancers at the 2025 Seattle Cellular Therapy Summit.
Rosa Nadal Rios, MD, PhD, on GU Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Rosa Nadal Rios, MD, PhD, shares insights on the future of cellular therapy in GU malignancies, highlighting advances in prostate, kidney, and testicular cancers at the 2025 Seattle Cellular Therapy Summit.
Rosa Nadal Rios, MD, PhD, on GU Malignancies—What is on the Horizon for Cellular Therapy?
By The Cancer News Team
Rosa Nadal Rios, MD, PhD, shares insights on the future of cellular therapy in GU malignancies, highlighting advances in prostate, kidney, and testicular cancers at the 2025 Seattle Cellular Therapy Summit.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.
Take a Loved One to the Doctor Day 2025: 3 Cancer Screening Facts That Could Save a Life
By The Cancer News Team
Take a Loved One to the Doctor Day 2025 highlights 3 essential cancer screening facts that can save lives by promoting early detection, prevention, and equity in care.
Take a Loved One to the Doctor Day 2025: 3 Cancer Screening Facts That Could Save a Life
By The Cancer News Team
Take a Loved One to the Doctor Day 2025 highlights 3 essential cancer screening facts that can save lives by promoting early detection, prevention, and equity in care.
Take a Loved One to the Doctor Day 2025: 3 Cancer Screening Facts That Could Save a Life
By The Cancer News Team
Take a Loved One to the Doctor Day 2025 highlights 3 essential cancer screening facts that can save lives by promoting early detection, prevention, and equity in care.
Childhood Cancer Awareness Month: Bridging Gaps and Saving Lives
By The Cancer News Team
Highlighting disparities, progress, and global efforts, this article for Childhood Cancer Awareness Month explores incidence, outcomes, and the urgent need to bridge gaps in pediatric cancer care.
Childhood Cancer Awareness Month: Bridging Gaps and Saving Lives
By The Cancer News Team
Highlighting disparities, progress, and global efforts, this article for Childhood Cancer Awareness Month explores incidence, outcomes, and the urgent need to bridge gaps in pediatric cancer care.
Childhood Cancer Awareness Month: Bridging Gaps and Saving Lives
By The Cancer News Team
Highlighting disparities, progress, and global efforts, this article for Childhood Cancer Awareness Month explores incidence, outcomes, and the urgent need to bridge gaps in pediatric cancer care.